Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 7Colorectal Neoplasms 7Colonic Neoplasms 3Rectal Neoplasms 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Klatskin Tumor 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1

Interventions

Cisplatin 47Radiotherapy 37Fluorouracil 23Cetuximab 17pembrolizumab 11Carboplatin 11Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 6Chemotherapy, Adjuvant 6Surgical Procedures, Operative 5Standard of Care 5nimotuzumab 4Methotrexate 4Gabapentin 4Drug Therapy 4Afatinib 4Radiotherapy, Conformal 3Radiation 3Porfiromycin 3Nivolumab 3Neoadjuvant Therapy 3Fibroblast Growth Factor 7 3Bleomycin 3zalutumumab 2sargramostim 2epacadostat 2Tranexamic Acid 2Tirapazamine 2Pilocarpine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Head and Neck Neoplasms × Tegafur × Clear all
NCT00336947 2013-05-15

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡